Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.

about

An evidence-based review of unoprostone isopropyl ophthalmic solution 0.15% for glaucoma: place in therapy

P2860

Q35125573-AC8FCA91-88EF-462E-B016-0408277E041B

P2860

Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.

Item

http://www.wikidata.org/entity/Q35589367

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Additive effect of unoprostone ...... elevated intraocular pressure.

@ast

Additive effect of unoprostone ...... elevated intraocular pressure.

@en

type

Item

label

Additive effect of unoprostone ...... elevated intraocular pressure.

@ast

Additive effect of unoprostone ...... elevated intraocular pressure.

@en

prefLabel

Additive effect of unoprostone ...... elevated intraocular pressure.

@ast

Additive effect of unoprostone ...... elevated intraocular pressure.

@en

P1476

Additive effect of unoprostone ...... elevated intraocular pressure.

@en

P2093

Boon-Ang Lim

http://www.w3.org/2001/XMLSchema#string

Francis T S Oen

http://www.w3.org/2001/XMLSchema#string

Jade Soh

http://www.w3.org/2001/XMLSchema#string

Lennard H Thean

http://www.w3.org/2001/XMLSchema#string

Leonard Yip

http://www.w3.org/2001/XMLSchema#string

Paul T K Chew

http://www.w3.org/2001/XMLSchema#string

Steve K L Seah

http://www.w3.org/2001/XMLSchema#string

Yiong-Huak Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure

Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.

Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol.

The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents.

Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients.

Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study.

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.

Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure.

The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.

P304

75-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.86.1.75

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tin Aung

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11801508

http://www.w3.org/2001/XMLSchema#string

P932

1770987

http://www.w3.org/2001/XMLSchema#string

Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.

about

P2860

P2860

Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932